财联社·2025-11-17 13:31Core Viewpoint - The article discusses the suspension of trading for two stocks, Haixia Innovation and Hefeng China, due to abnormal price fluctuations that significantly deviate from their fundamental performance [1][3]. Group 1: Haixia Innovation - Haixia Innovation's stock price increased by 185.89% from October 27 to November 17, leading to three instances of abnormal trading [1]. - The company announced a suspension of trading starting November 18, pending an investigation into the stock price fluctuations, expected to last no more than three trading days [1]. - Despite the stock price surge, Haixia Innovation reported a net loss of 22.61 million yuan in Q3, with a revenue of 19.34 million yuan, reflecting a 2.25% year-on-year increase [3]. Group 2: Hefeng China - Hefeng China experienced a cumulative stock price increase of 256.29% from October 28 to November 14, with 12 out of 14 trading days closing at the daily limit [4]. - The company also faced multiple instances of abnormal trading, prompting a suspension for investigation [4]. - Prior to the suspension, Hefeng China issued warnings about the disconnect between its stock price and operational performance, advising investors to be cautious [4].